Advanced search
Publication Cover
Expert Opinion on Medical Diagnostics Volume 2, 2008 - Issue 6
Journal homepage
64
Views
22
CrossRef citations to date
0
Altmetric
Review

Dipeptidyl peptidase-IV and related molecules: markers of malignancy?

Aleksi Šedo Charles University in Prague, Laboratory of Cancer Cell Biology of the 1st Faculty of Medicine, U Nemocnice 5, 128 53, Prague 2, Czech Republic, +420 728 748 692; +420 224 965 826; [email protected]; The Institute of Physiology, Academy of Sciences, Videnska 1083, 14220, Prague 4, Czech Republic
, MD PhD (Professor, University Teacher, Scientist) ,
Jarmila Stremenová Charles University in Prague, Laboratory of Cancer Cell Biology of the 1st Faculty of Medicine, U Nemocnice 5, 128 53, Prague 2, Czech Republic, +420 728 748 692; +420 224 965 826; [email protected]; The Institute of Physiology, Academy of Sciences, Videnska 1083, 14220, Prague 4, Czech Republic
, MSc (University Teacher, PhD Student) ,
Petr Bušek Charles University in Prague, Laboratory of Cancer Cell Biology of the 1st Faculty of Medicine, U Nemocnice 5, 128 53, Prague 2, Czech Republic, +420 728 748 692; +420 224 965 826; [email protected]; The Institute of Physiology, Academy of Sciences, Videnska 1083, 14220, Prague 4, Czech Republic
, MD (University Teacher, PhD Student) &
Jonathan S Duke-Cohan Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA
, PhD (University Teacher, Scientist)
Pages 677-689 | Published online: 04 Jun 2008

Bibliography

  • Hopsu-Havu VK, Glenner GG. A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie 1966;7:197-201
  • Lambeir AM, Durinx C, Scharpe S, et al. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 2003;40:209-94
  • Hegen M, Niedobitek G, Klein CE, et al. The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J Immunol 1990;144:2908-14
  • Fox DA, Hussey RE, Fitzgerald KA, et al. Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J Immunol 1984;133:1250-6
  • Vanhoof G, Goossens F, De Meester I, et al. Proline motifs in peptides and their biological processing. FASEB J 1995;9:736-44
  • Yaron A, Naider F. Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol 1993;28:31-81
  • Mentlein R. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept 1999;85:9-24
  • Sedo A, Malik R. Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities? Biochim Biophys Acta 2001;1550:107-16
  • Morimoto C, Schlossman SF. The structure and function of CD26 in the T-cell immune response. Immunol Rev 1998;161:55-70
  • Pacheco R, Martinez-Navio JM, Lejeune M, et al. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc Natl Acad Sci USA 2005;102:9583-8
  • Ren X, Hayashi Y, Yoshimura N, et al. Transmembrane interaction mediates complex formation between peptidase homologues and Kv4 channels. Mol Cell Neurosci 2005;29:320-32
  • Ghersi G, Zhao Q, Salamone M, et al. The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices. Cancer Res 2006;66:4652-61
  • Sedo A, Duke-Cohan JS, Balaziova E, et al. Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis? Arthritis Res Ther 2005;7:253-69
  • Reinhold D, Bank U, Tager M, et al. DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis. Front Biosci 2008;13:2356-63
  • Hildebrandt M, Rose M, Ruter J, et al. Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease. Scand J Gastroenterol 2001;36:1067-72
  • Durinx C, Lambeir AM, Bosmans E, et al. Molecular characterization of dipeptidyl peptidase activity in serum – soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur J Biochem 2000;267:5608-13
  • Oravecz T, Pall M, Roderiquez G, et al. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J Exp Med 1997;186:1865-72
  • Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007;28:299-307
  • Dano K, Behrendt N, Hoyer-Hansen G, et al. Plasminogen activation and cancer. Thromb Haemost 2005;93:676-81
  • Gonzalez-Gronow M, Kaczowka S, Gawdi G, et al. Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor. Front Biosci 2008;13:1610-8
  • Kameoka J, Tanaka T, Nojima Y, et al. Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 1993;261:466-9
  • Tan EY, Richard CL, Zhang H, et al. Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway. Am J Physiol Cell Physiol 2006;291:C433-44
  • Davoodi J, Kelly J, Gendron NH, et al. The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26. Proteomics 2007;7:2300-10
  • Friedrich D, Hoffmann T, Bar J, et al. Does human attractin have DP4 activity? Biol Chem 2007;388:155-62
  • Barinka C, Rinnova M, Sacha P, et al. Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II. J Neurochem 2002;80:477-87
  • Blanc G, Font B, Eichenberger D, et al. Insights into how CUB domains can exert specific functions while sharing a common fold: conserved and specific features of the CUB1 domain contribute to the molecular basis of procollagen C-proteinase enhancer-1 activity. J Biol Chem 2007;282:16924-33
  • Wermter C, Howel M, Hintze V, et al. The protease domain of procollagen C-proteinase (BMP1) lacks substrate selectivity, which is conferred by non-proteolytic domains. Biol Chem 2007;388:513-21
  • Khwaja FW, Duke-Cohan JS, Brat DJ, et al. Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration. Clin Cancer Res 2006;12:6331-6
  • Tang W, Duke-Cohan JS. Human secreted attractin disrupts neurite formation in differentiating cortical neural cells in vitro. J Neuropathol Exp Neurol 2002;61:767-77
  • Hagihara M, Mihara R, Togari A, et al. Dipeptidyl-aminopeptidase II in human cerebrospinal fluid: changes in patients with Parkinson's disease. Biochem Med Metab Biol 1987;37:360-5
  • Maes MB, Scharpe S, De Meester I. Dipeptidyl peptidase II (DPPII), a review. Clin Chim Acta 2007;380:31-49
  • Maes MB, Martinet W, Schrijvers DM, et al. Dipeptidyl peptidase II and leukocyte cell death. Biochem Pharmacol 2006;72:70-9
  • Lee J, Fassnacht M, Nair S, et al. Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts. Cancer Res 2005;65:11156-63
  • Park JE, Lenter MC, Zimmermann RN, et al. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem 1999;274:36505-12
  • O'Brien P, O'Connor BF. Seprase: an overview of an important matrix serine protease. Biochim Biophys Acta 2008; [Epub ahead of print]. DOI: 10.1016/j.bbapap.2008.01.006
  • Lee KN, Jackson KW, Christiansen VJ, et al. Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein. Blood 2006;107:1397-404
  • Yu DM, Wang XM, McCaughan GW, et al. Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis. FEBS J 2006;273:2447-60
  • Radicke S, Cotella D, Graf EM, et al. Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative beta-subunit of human cardiac transient outward current encoded by Kv4.3. J Physiol (Lond) 2005;565:751-6
  • Jerng HH, Qian Y, Pfaffinger PJ. Modulation of Kv4.2 channel expression and gating by dipeptidyl peptidase 10 (DPP10). Biophys J 2004;87:2380-96
  • McIntosh CH. Dipeptidyl peptidase IV inhibitors and diabetes therapy. Front Biosci 2008;13:1753-73
  • Deacon CF, Carr RD, Holst JJ. DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes. Front Biosci 2008;13:1780-94
  • Campbell TB, Broxmeyer HE. CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation. Front Biosci 2008;13:1795-805
  • Ahren B. Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications. Diabetes Care 2007;30:1344-50
  • Christopherson KW 2nd, Hangoc G, Mantel CR, et al. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004;305:1000-3
  • Busek P, Malik R, Sedo A. Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer. Int J Biochem Cell Biol 2004;36:408-21
  • Narra K, Mullins SR, Lee HO, et al. Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer. Cancer Biol Ther 2007;6:1691-9
  • Wesley UV, Albino AP, Tiwari S, et al. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med 1999;190:311-22
  • Pethiyagoda CL, Welch DR, Fleming TP. Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells. Clin Exp Metastasis 2000;18:391-400
  • Houghton AN, Albino AP, Cordon-Cardo C, et al. Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation. J Exp Med 1988;167:197-212
  • Kajiyama H, Kikkawa F, Suzuki T, et al. Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma. Cancer Res 2002;62:2753-7
  • Kikkawa F, Kajiyama H, Shibata K, et al. Dipeptidyl peptidase IV in tumor progression. Biochim Biophys Acta Proteins Proteomics 2005;1751:45-51
  • Wesley UV, Tiwari S, Houghton AN. Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells. Int J Cancer 2004;109:855-66
  • Wesley UV, McGroarty M, Homoyouni A. Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. Cancer Res 2005;65:1325-34
  • Busek P, Stremenova J, Sedo A. Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors-good or evil? Front Biosci 2008;13:2319-26
  • Loster K, Zeilinger K, Schuppan D, et al. The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site. Biochem Biophys Res Commun 1995;217:341-8
  • Cheng HC, Abdel-Ghany M, Elble RC, et al. Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin. J Biol Chem 1998;273:24207-15
  • Kajiyama H, Kikkawa F, Khin E, et al. Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells. Cancer Res 2003;63:2278-83
  • Iwata S, Morimoto C. CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation. J Exp Med 1999;190:301-6
  • Van den Oord JJ. Expression of CD26/dipeptidyl-peptidase IV in benign and malignant pigment-cell lesions of the skin. Br J Dermatol 1998;138:615-21
  • Roesch A, Wittschier S, Becker B, et al. Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating nevi. Mod Pathol 2006;19:1378-85
  • Khin EE, Kikkawa F, Ino K, et al. Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumor grade. Am J Obstet Gynecol 2003;188:670-6
  • Kajiyama H, Kikkawa F, Ino K, et al. Expression of CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma and its negative correlation with tumor grade. Dipeptidyl Aminopeptidases Health Dis 2003;524:245-8
  • Hirai K, Kotani T, Aratake Y, et al. Dipeptidyl peptidase IV (DPP IV/CD26) staining predicts distant metastasis of ‘benign’ thyroid tumor. Pathol Int 1999;49:264-5
  • de Micco C, Savchenko V, Giorgi R, et al. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV. Br J Cancer 2008;98:818-23
  • Stremenova J, Krepela E, Mares V, et al. Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade. Int J Oncol 2007;31:785-92
  • Inamoto T, Yamada T, Ohnuma K, et al. Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors. Clin Cancer Res 2007;13:4191-200
  • Inamoto T, Yamochi T, Ohnuma K, et al. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix. Clin Cancer Res 2006;12:3470-7
  • Wilson MJ, Haller R, Li SY, et al. Elevation of dipeptidylpeptidase iv activities in the prostate peripheral zone and prostatic secretions of men with prostate cancer: possible prostate cancer disease marker. J Urol 2005;174:1124-8
  • Wilson MJ, Ruhland AR, Quast BJ, et al. Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands. J Androl 2000;21:220-6
  • Bogenrieder T, Finstad CL, Freeman RH, et al. Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue. Prostate 1997;33:225-32
  • Sedo A, Krepela E, Kasafirek E. Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma. J Cancer Res Clin Oncol 1991;117:249-53
  • Asada Y, Aratake Y, Kotani T, et al. Expression of dipeptidyl aminopeptidase IV activity in human lung carcinoma. Histopathology 1993;23:265-70
  • Kojima J, Ueno Y, Kasugai H, et al. Glycylproline dipeptidyl aminopeptidase and gamma-glutamyl-transferase transpeptidase in human hepatic cancer and embryonal tissues. Clin Chim Acta 1987;167:285-91
  • Moehrle MC, Schlagenhauff BE, Klessen C, et al. Aminopeptidase-M and dipeptidyl peptidase-IV activity in epithelial skin tumors - a histochemical-study. J Cutan Pathol 1995;22:241-7
  • Ruiz P, Mailhot S, Delgado P, et al. CD26 expression and dipeptidyl peptidase IV activity in an aggressive hepatosplenic T-cell lymphoma. Cytometry 1998;34:30-5
  • Dang NH, Aytac U, Sato K, et al. T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition. Br J Haematol 2003;121:857-65
  • Carbone A, Gloghini A, Zagonel V, et al. The expression of Cd26 and Cd40 ligand is mutually exclusive in human T-cell non-Hodgkins-lymphomas leukemias. Blood 1995;86:4617-26
  • Kari L, Loboda A, Nebozhyn M, et al. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med 2003;197:1477-88
  • Jones D, Dang NH, Duvic M, et al. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol 2001;115:885-92
  • Kelemen K, Guitart J, Kuzel TM, et al. The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sezary syndrome. Am J Clin Pathol 2008;129:146-56
  • Tsuji T, Sugahara K, Tsuruda K, et al. Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells. Int J Hematol 2004;80:254-60
  • Krepela E, Prochazka J, Mynarikova H, et al. Lysosomal dipeptidyl-peptidases I and II in human squamous cell lung carcinoma and lung parenchyma. Neoplasma 1996;43:171-8
  • Klener P, Lojda Z, Haber J, et al. Possible prognostic-significance of the assessment of dipeptidylpeptidase-II in peripheral-blood lymphocytes of patients with chronic lymphocytic-leukemia. Neoplasma 1987;34:581-6
  • Danilov AV, Klein AK, Lee HJ, et al. Differential control of G0 programme in chronic lymphocytic leukaemia: a novel prognostic factor. Br J Haematol 2005;128:472-81
  • Ramirez-Montagut T, Blachere NE, Sviderskaya EV, et al. FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene 2004;23:5435-46
  • Huber MA, Kraut N, Park JE, et al. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. J Invest Dermatol 2003;120:182-8
  • Mori Y, Kono K, Matsumoto Y, et al. The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma. Oncology 2004;67:411-9
  • Okada K, Chen WT, Iwasa S, et al. Seprase, a membrane-type serine protease, has different expression patterns in intestinal- and diffuse-type gastric cancer. Oncology 2003;65:363-70
  • Jin X, Iwasa S, Okada K, et al. Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm. Anticancer Res 2003;23:3195-8
  • Henry LR, Lee HO, Lee JS, et al. Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res 2007;13:1736-41
  • Iwasa S, Okada K, Chen WT, et al. Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer. Cancer Lett 2005;227:229-36
  • Zhang MZ, Qiao YH, Nesland JM, et al. Expression of seprase in effusions from patients with epithelial ovarian carcinoma. Chin Med J 2007;120:663-8
  • Chen DH, Kennedy A, Wang JY, et al. Activation of EDTA-resistant gelatinases in malignant human tumors. Cancer Res 2006;66:9977-85
  • Hino M, Nagatsu T, Kakumu S, et al. Glycylprolyl beta-naphthylamidase activity in human-serum. Clin Chim Acta 1975;62:5-11
  • Ni RZ, Huang JF, Xiao MB, et al. Glycylproline dipeptidyl aminopeptidase isoenzyme in diagnosis of primary hepatocellular carcinoma. World J Gastroenterol 2003;9:710-3
  • Cordero OJ, Ayude D, Nogueira M, et al. Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer. Br J Cancer 2000;83:1139-46
  • de la Haba-Rodriguez J, Macho A, Calzado MA, et al. Soluble dipeptidyl peptidase IV (CD-26) in serum of patients with colorectal carcinoma. Neoplasma 2002;49:307-11
  • Urade M, Komatsu M, Yamaoka M, et al. Serum dipeptidyl peptidase activities as a possible marker of oral-cancer. Cancer 1989;64:1274-80
  • Collins PJ, McMahon G, O'Brien P, et al. Purification, identification and characterisation of seprase from bovine serum. Int J Biochem Cell Biol 2004;36:2320-33
  • Duffy M. Role of tumor markers in patients with solid cancers: a critical review. Eur J Intern Med 2007;18:175-84
  • Hiramatsu H, Yamamoto A, Kyono K, et al. The crystal structure of human dipeptidyl peptidase IV (DPPIV) complex with diprotin A. Biol Chem 2004;385:561-4
  • Engel M, Hoffmann T, Manhart S, et al. Rigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIV. J Mol Biol 2006;355:768-83
  • Biftu T, Scapin G, Singh S, et al. Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin. Bioorg Med Chem Lett 2007;17:3384-7
  • Kehlen A, Lendeckel U, Dralle H, et al. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas. Cancer Res 2003;63:8500-6
  • Kotani T, Aratake Y, Ogata Y, et al. Expression of dipeptidyl aminopeptidase-IV activity in thyroid-carcinoma. Cancer Lett 1991;57:203-8
  • Iwabuchi H, Toriya K, Mimura T, et al. Staining for dipeptidyl aminopeptidase IV activity in nodular thyroid diseases. Acta Cytol 1996;40:158-63
  • Tanaka T, Umeki K, Yamamoto I, et al. CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma. Int J Cancer 1995;64:326-31
  • Aratake Y, Umeki K, Kiyoyama K, et al. Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules. Diagn Cytopathol 2002;26:366-72
  • Tang AC, Raphael SJ, Lampe HB, et al. Expression of dipeptidyl aminopeptidase IV activity in thyroid tumours: a possible marker of thyroid malignancy. J Otolaryngol 1996;25:14-9
  • Kelly T, Kechelava S, Rozypal TL, et al. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Mod Pathol 1998;11:855-63
  • Ariga N, Sato E, Ohuchi N, et al. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int J Cancer 2001;95:67-72
  • Rettig WJ, Garin-Chesa P, Healey JH, et al. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res 1993;53:3327-35
  • Haacke W, Kullertz G, Barth A. Investigations into the diagnostic usefulness of the enzyme dipeptidylpeptidase-IV (DP-IV) in abdominal diseases. Z Klin Med 1986;41:235-9
  • Fujita K, Hirano M, Tokunaga K, et al. Serum glycylproline para-nitroanilidase activity in blood cancers. Clin Chim Acta 1977;81:215-7
  • Fukasawa K, Harada M, Komatsu M, et al. Serum dipeptidyl peptidase (Dpp)-IV activities in oral-cancer patients. Int J Oral Surg 1982;11:246-50
  • Uematsu T, Urade M, Yamaoka M. Decreased expression and release of dipeptidyl peptidase IV (CD26) in cultured peripheral blood T lymphocytes of oral cancer patients. J Oral Pathol Med 1998;27:106-10
  • Mogi M, Harada M, Hiraoka BY, et al. Sandwich enzyme-immunoassay for dipeptidyl aminopeptidase-IV in the serum of people with oral-cancer. Arch Oral Biol 1986;31:505-7
  • Sedo A, Hatle K, Stolba P. Changes in dipeptidyl-peptidase IV activity in human serum in pathological conditions of the thyroid gland. Cas Lek Cesk 1985;124:1579-81
  • Kojima J, Kanatani M, Kato M, et al. Serum glycylproline dipeptidyl aminopeptidase activity in human hepatic cancer. Clin Chim Acta 1979;93:181-7
  • Index of Peptidase Names. Available from: http://merops.sanger.ac.uk/cgi-bin/name_index?id = P;action = A

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.